{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.98 vs. cons $1.94",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted net revenue",
      "prediction": "BEAT",
      "answer": "pred ~$2.38B vs. cons $2.35B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA margin",
      "prediction": "IN-LINE",
      "answer": "pred ~15.1% vs. cons 15.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$7.10-$7.35 (midpoint $7.23) vs. cons $7.24 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EBITDA-margin guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~14.6%-14.9% (midpoint 14.75%) vs. cons 14.75% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted free-cash-flow-margin guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.0%-8.5% (midpoint 7.75%) vs. cons 7.80% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "FADE",
  "day5_rationale": "Day 1 residual ~+2.5% versus Day 5 residual ~+1.0%: a modest EPS/revenue beat and clean ~15% margin execution should drive an initial positive reaction, but unchanged FY2026 EPS and margin ranges leave the implied Q4 step-up and FY2027 estimate risk largely unresolved, limiting out-period revisions.",
  "day5_confidence": "MEDIUM"
}